Mark McDade
Mark McDade is Co-founder and Partner at Qiming Venture Partners USA. He was EVP and Chief Operating Officer at UCB and CEO at PDL BioPharma. He was Chief Executive Officer at Signature BioScience, Co-founder and COO at Corixa Corporation, and COO at Boehringer Mannheim Therapeutics. He is chairman of Icosavax, a director of Lupin Ltd. and a trustee of the National Marine Sanctuary Foundation, and was chairman of Aimmune Therapeutics and a director of Dermira, Inc.
Recent coverage
Front-page news, podcasts and videos about Mark
Icosavax raises $51M Series A led by Qiming to build computer-designed VLP vaccines, starting with an adult RSV shot
Icosavax, a University of Washington spinout, raised $51 million in a Series A led by Qiming Venture Partners USA to develop computer-designed virus-like particle vaccines, starting with an adult RSV vaccine and planning broader applications.
Organizations
See all 6-
Qiming Venture Partners USA Co Founder and Partner 2017–present · current
-
UCB EVP and Chief Operating Officer 2008–2016 · past
-
PDL BioPharma CEO 2002–2007 · past
Education
-
Harvard Business School 1982–1984
-
Dartmouth College Bachelor of Arts (B.A.), History · 1973–1977
Online
Questions about Mark McDade
Who is Mark McDade?
Mark McDade is Co Founder and Partner at Qiming Venture Partners USA.
Which organizations is Mark McDade associated with?
On Seattle Flow, Mark McDade is listed with Qiming Venture Partners USA, UCB, PDL BioPharma and 3 more.
Where did Mark McDade study?
Mark McDade studied at Harvard Business School and Dartmouth College.
Where is Mark McDade based?
Mark McDade is based in Seattle, Washington, United States.
Where can I find Mark McDade online?
Mark McDade is on LinkedIn.